{"id":2637,"date":"2021-02-09T02:19:21","date_gmt":"2021-02-09T02:19:21","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2637"},"modified":"2023-08-29T18:01:52","modified_gmt":"2023-08-29T18:01:52","slug":"alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2637","title":{"rendered":"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9"},"content":{"rendered":"<p>\u751f\u7269\u6280\u672f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=ATH&amp;lang=cn\">Alterity Therapeutics (ASX: ATH)<\/a>\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002<\/p>\n<p>\u8fd9\u7b1449.5\u4e07\u7f8e\u5143(64.15\u4e07\u6fb3\u5143)\u7684\u8d44\u91d1\u662f\u8be5\u516c\u53f8\u4ece\u8be5\u57fa\u91d1\u4f1a\u83b7\u5f97\u7684\u7b2c\u4e8c\u7b14\u8d44\u91d1\uff0c\u5c06\u7528\u4e8e\u5728\u7075\u957f\u7c7b\u52a8\u7269\u6a21\u578b\u4e2d\u8bc4\u4f30ATH434\u7684\u836f\u7406\u7279\u6027\uff0c\u4ee5\u786e\u5b9a\u672a\u6765\u8bd5\u9a8c\u7684\u5242\u91cf\u3002<\/p>\n<p>Alterity\u6b63\u8bd5\u56fe\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u7684\u6839\u672c\u539f\u56e0\uff0c\u7279\u522b\u662f\u591a\u7cfb\u7edf\u840e\u7f29(MSA)\u3002<\/p>\n<p>\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u8bc4\u4f30\u4e86\u5176\u5148\u5bfc\u836f\u7269ATH434\u5728\u5065\u5eb7\u6210\u4eba\u548c\u8001\u5e74\u5fd7\u613f\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u3002<\/p>\n<p>\u636eAlterity<a href=\"http:\/\/smallcaps-production.test\/dr-david-stamler-chief-executive-officer-alterity-therapeutics\/?lang=cn\">\u65b0\u4efb\u547d\u7684\u9996\u5e2d\u6267\u884c\u5b98David Stamler\u535a\u58eb<\/a>\u4ecb\u7ecd\uff0cMSA\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5c06\u4e8e\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u5f00\u59cb\u3002<\/p>\n<p>\u201cATH434\u76ee\u6807\u03b1-\u7a81\u89e6\u6838\u86cb\u767d\u901a\u8fc7\u518d\u5206\u914d\u591a\u4f59\u7684\u9519\u8bef\u6298\u53e0\u548c\u805a\u96c6\u4e0d\u7a33\u5b9a\u94c1\u2026\u2026\u53ef\u80fd\u6269\u5c55\u5230\u5176\u4ed6\u5e15\u91d1\u68ee\u75be\u75c5\u6d89\u53ca\u5230\u03b1-\u7a81\u89e6\u6838\u86cb\u767d\u4e00\u76f4\u662f\u6211\u4eec\u7684\u6218\u7565\u7684\u4e00\u90e8\u5206,\u8fd9\u4e9b\u8d44\u91d1\u5141\u8bb8\u6211\u4eec\u518d\u4e00\u6b65\u5b9e\u73b0\u4e00\u4e2a\u7a0b\u5e8f\u5728\u5e15\u91d1\u68ee\u75c5,\u201d\u4ed6\u8bf4\u3002<\/p>\n<p>Stamler\u535a\u58eb\u5c06Michael J Fox\u57fa\u91d1\u4f1a\u63cf\u8ff0\u4e3a\u201c\u4e00\u4e2a\u4e0d\u53ef\u601d\u8bae\u7684\u7ec4\u7ec7\uff0c\u7ad9\u5728\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u548c\u6cbb\u7597\u521b\u65b0\u7684\u524d\u6cbf\u3002\u5e15\u91d1\u68ee\u75c5\u81f3\u4eca\u65e0\u6cd5\u6cbb\u6108\uff0c\u5f71\u54cd\u7740\u5168\u7403\u7ea6700\u4e07\u81f31000\u4e07\u4eba\u3002\u201d<\/p>\n<h2>\u7b2c\u4e8c\u5e38\u89c1\u7684\u5e74\u9f84\u76f8\u5173\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5<\/h2>\n<p>\u6839\u636eAlterity\u7684\u7814\u7a76\uff0c\u5e15\u91d1\u68ee\u6c0f\u75c7\u662f\u4ec5\u6b21\u4e8e\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u7684\u7b2c\u4e8c\u5927\u4e0e\u5e74\u9f84\u6709\u5173\u7684\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002\u591a\u5df4\u80fa\u662f\u63a7\u5236\u8fd0\u52a8\u7684\u5316\u5b66\u7269\u8d28\uff0c\u5f53\u4ea7\u751f\u591a\u5df4\u80fa\u7684\u8111\u7ec6\u80de\u9000\u5316\u5e76\u6700\u7ec8\u6b7b\u4ea1\u65f6\uff0c\u591a\u5df4\u80fa\u5c31\u4f1a\u53d1\u751f\u3002<\/p>\n<p>\u8fd9\u79cd\u60c5\u51b5\u88ab\u8ba4\u4e3a\u662f\u4e00\u79cd\u201c\u8fd0\u52a8\u969c\u788d\u201d\uff0c\u56e0\u4e3a\u5b83\u53ef\u4ee5\u5bfc\u81f4\u9707\u98a4\u3001\u8fdf\u7f13\u3001\u50f5\u786c\u4ee5\u53ca\u5e73\u8861\u548c\u884c\u8d70\u65b9\u9762\u7684\u95ee\u9898\u3002\u7136\u800c\uff0c\u5b83\u4e5f\u4f1a\u5f15\u8d77\u975e\u8fd0\u52a8\u75c7\u72b6\uff0c\u5305\u62ec\u4fbf\u79d8\u3001\u6291\u90c1\u548c\u8bb0\u5fc6\u529b\u53d7\u635f\u3002<\/p>\n<p>\u8fd9\u662f\u4e00\u79cd\u7ec8\u8eab\u7684\u8fdb\u884c\u6027\u75be\u75c5\uff0c\u4e5f\u5c31\u662f\u8bf4\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\uff0c\u75c7\u72b6\u4f1a\u6162\u6162\u6076\u5316\u3002<\/p>\n<p>\u76ee\u524d\u6709\u5c11\u91cf\u7684\u6cbb\u7597\u65b9\u6cd5\u53ef\u4ee5\u6cbb\u7597\u67d0\u4e9b\u75c7\u72b6\uff0c\u4f46\u76ee\u524d\u8fd8\u65e0\u6cd5\u6cbb\u6108\u3002\u5e15\u91d1\u68ee\u75c5\u60a3\u8005\u6025\u9700\u65b0\u7684\u6cbb\u7597\u65b9\u6cd5\u6765\u51cf\u7f13\u6216\u963b\u6b62\u75be\u75c5\u7684\u8fdb\u5c55\uff0c\u63d0\u9ad8\u751f\u6d3b\u8d28\u91cf\u3002<\/p>\n<p>\u201d\u805a\u96c6\u7684\u86cb\u767d\u8d28\u9519\u8bef\u6298\u53e0\u03b1-\u7a81\u89e6\u6838\u86cb\u767d\u5e7f\u6cdb\u5206\u5e03\u4e8e\u4e2a\u4eba\u7684\u5927\u8111\u53d7\u8fd9\u4e9b\u75be\u75c5\u5f71\u54cd,\u51cf\u5c11\u7d2f\u79ef,ATH434\u6f5c\u5728\u6539\u5584\u8fd9\u4e9b\u6bc1\u706d\u6027\u7684\u6761\u4ef6\u7684\u975e\u673a\u52a8\u8f66\u53d1\u52a8\u673a\u548c\u75c7\u72b6,\u201d\u6c83\u7eb3Poewe\u535a\u58eb\u7814\u7a76\u5458\u8fc8\u514b\u5c14J\u798f\u514b\u65af\u57fa\u91d1\u4f1a\u548c\u5965\u5730\u5229\u56e0\u65af\u5e03\u9c81\u514b\u533b\u79d1\u5927\u5b66\u7684\u795e\u7ecf\u5b66\u6559\u6388,\u8bf4\u3002<\/p>\n<p>\u201c\u6211\u671f\u5f85\u770b\u5230\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5242\u91cf\u4f18\u5316\u7814\u7a76\u7684\u7ed3\u679c\uff0c\u4ee5\u53ca\u8fd9\u4e00\u9002\u5e94\u75c7\u7684\u672a\u6765\u53d1\u5c55\uff0c\u201d\u4ed6\u8865\u5145\u9053\u3002<\/p>\n<p>\u8be5\u9879\u76ee\u5c06\u7531\u8303\u5fb7\u6bd4\u5c14\u7279\u5927\u5b66\u533b\u5b66\u4e2d\u5fc3\u975e\u4e34\u5e8a\u53d1\u5c55\u526f\u4e3b\u4efbMargaret Bradbury\u535a\u58eb\u3001\u795e\u7ecf\u75c5\u5b66\u526f\u6559\u6388Daniel Claassen\u535a\u58eb\u4ee5\u53ca\u5f17\u6d1b\u91cc\u795e\u7ecf\u79d1\u5b66\u548c\u7cbe\u795e\u5065\u5eb7\u7814\u7a76\u6240PD\u7814\u7a76\u5b9e\u9a8c\u5ba4\u4e3b\u4efbDavid Finkelstein\u535a\u58eb\u9886\u5bfc\u3002<\/p>\n<h2>\u5bfb\u627e\u6cbb\u7597\u65b9\u6cd5<\/h2>\n<p>Michael J Fox\u57fa\u91d1\u4f1a\u4e8e2000\u5e74\u7531\u597d\u83b1\u575e\u8457\u540d\u6f14\u5458\u3001<em>Back to the Future<\/em>\u4e2d\u7684\u660e\u661fMichael J Fox\u521b\u7acb\u30021991\u5e74\uff0c29\u5c81\u7684\u8fc8\u514b\u5c14\u88ab\u8bca\u65ad\u51fa\u60a3\u6709\u5e15\u91d1\u68ee\u75c7\u3002<\/p>\n<p>\u8be5\u57fa\u91d1\u4f1a\u81f4\u529b\u4e8e\u901a\u8fc7\u79ef\u6781\u8d44\u52a9\u7684\u7814\u7a76\u8bae\u7a0b\u627e\u5230\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u7684\u65b9\u6cd5\uff0c\u5e76\u786e\u4fdd\u6539\u5584\u6cbb\u7597\u65b9\u6cd5\u7684\u53d1\u5c55\uff0c\u4e3a\u4eca\u5929\u7684\u5e15\u91d1\u68ee\u60a3\u8005\u63d0\u4f9b\u5e2e\u52a9\u3002<\/p>\n<p>\u8be5\u57fa\u91d1\u4f1a\u58f0\u79f0\u8fc4\u4eca\u4e3a\u6b62\u5df2\u7ecf\u8d44\u52a9\u4e86\u8d85\u8fc710\u4ebf\u7f8e\u5143(13\u4ebf\u6fb3\u5143)\u7684\u7814\u7a76\u9879\u76ee\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002 \u8fd9\u7b1449.5\u4e07\u7f8e\u5143(64.15\u4e07\u6fb3\u5143)\u7684\u8d44\u91d1\u662f\u8be5\u516c\u53f8\u4ece\u8be5\u57fa\u91d1\u4f1a\u83b7\u5f97\u7684\u7b2c\u4e8c\u7b14\u8d44\u91d1\uff0c\u5c06\u7528\u4e8e\u5728\u7075\u957f\u7c7b\u52a8\u7269\u6a21\u578b\u4e2d\u8bc4\u4f30ATH434\u7684\u836f\u7406\u7279\u6027\uff0c\u4ee5\u786e\u5b9a\u672a\u6765\u8bd5\u9a8c\u7684\u5242\u91cf\u3002 Alterity\u6b63\u8bd5\u56fe\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u7684\u6839\u672c\u539f\u56e0\uff0c\u7279\u522b\u662f\u591a\u7cfb\u7edf\u840e\u7f29(MSA)\u3002 \u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u8bc4\u4f30\u4e86\u5176\u5148\u5bfc\u836f\u7269ATH434\u5728\u5065\u5eb7\u6210\u4eba\u548c\u8001\u5e74\u5fd7\u613f\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u3002 \u636eAlterity\u65b0\u4efb\u547d\u7684\u9996\u5e2d\u6267\u884c\u5b98David Stamler\u535a\u58eb\u4ecb\u7ecd\uff0cMSA\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5c06\u4e8e\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u5f00\u59cb\u3002 \u201cATH434\u76ee\u6807\u03b1-\u7a81\u89e6\u6838\u86cb\u767d\u901a\u8fc7\u518d\u5206\u914d\u591a\u4f59\u7684\u9519\u8bef\u6298\u53e0\u548c\u805a\u96c6\u4e0d\u7a33\u5b9a\u94c1\u2026\u2026\u53ef\u80fd\u6269\u5c55\u5230\u5176\u4ed6\u5e15\u91d1\u68ee\u75be\u75c5\u6d89\u53ca\u5230\u03b1-\u7a81\u89e6\u6838\u86cb\u767d\u4e00\u76f4\u662f\u6211\u4eec\u7684\u6218\u7565\u7684\u4e00\u90e8\u5206,\u8fd9\u4e9b\u8d44\u91d1\u5141\u8bb8\u6211\u4eec\u518d\u4e00\u6b65\u5b9e\u73b0\u4e00\u4e2a\u7a0b\u5e8f\u5728\u5e15\u91d1\u68ee\u75c5,\u201d\u4ed6\u8bf4\u3002 Stamler\u535a\u58eb\u5c06Michael J Fox\u57fa\u91d1\u4f1a\u63cf\u8ff0\u4e3a\u201c\u4e00\u4e2a\u4e0d\u53ef\u601d\u8bae\u7684\u7ec4\u7ec7\uff0c\u7ad9\u5728\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u548c\u6cbb\u7597\u521b\u65b0\u7684\u524d\u6cbf\u3002\u5e15\u91d1\u68ee\u75c5\u81f3\u4eca\u65e0\u6cd5\u6cbb\u6108\uff0c\u5f71\u54cd\u7740\u5168\u7403\u7ea6700\u4e07\u81f31000\u4e07\u4eba\u3002\u201d \u7b2c\u4e8c\u5e38\u89c1\u7684\u5e74\u9f84\u76f8\u5173\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5 \u6839\u636eAlterity\u7684\u7814\u7a76\uff0c\u5e15\u91d1\u68ee\u6c0f\u75c7\u662f\u4ec5\u6b21\u4e8e\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u7684\u7b2c\u4e8c\u5927\u4e0e\u5e74\u9f84\u6709\u5173\u7684\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002\u591a\u5df4\u80fa\u662f\u63a7\u5236\u8fd0\u52a8\u7684\u5316\u5b66\u7269\u8d28\uff0c\u5f53\u4ea7\u751f\u591a\u5df4\u80fa\u7684\u8111\u7ec6\u80de\u9000\u5316\u5e76\u6700\u7ec8\u6b7b\u4ea1\u65f6\uff0c\u591a\u5df4\u80fa\u5c31\u4f1a\u53d1\u751f\u3002 \u8fd9\u79cd\u60c5\u51b5\u88ab\u8ba4\u4e3a\u662f\u4e00\u79cd\u201c\u8fd0\u52a8\u969c\u788d\u201d\uff0c\u56e0\u4e3a\u5b83\u53ef\u4ee5\u5bfc\u81f4\u9707\u98a4\u3001\u8fdf\u7f13\u3001\u50f5\u786c\u4ee5\u53ca\u5e73\u8861\u548c\u884c\u8d70\u65b9\u9762\u7684\u95ee\u9898\u3002\u7136\u800c\uff0c\u5b83\u4e5f\u4f1a\u5f15\u8d77\u975e\u8fd0\u52a8\u75c7\u72b6\uff0c\u5305\u62ec\u4fbf\u79d8\u3001\u6291\u90c1\u548c\u8bb0\u5fc6\u529b\u53d7\u635f\u3002 \u8fd9\u662f\u4e00\u79cd\u7ec8\u8eab\u7684\u8fdb\u884c\u6027\u75be\u75c5\uff0c\u4e5f\u5c31\u662f\u8bf4\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\uff0c\u75c7\u72b6\u4f1a\u6162\u6162\u6076\u5316\u3002 \u76ee\u524d\u6709\u5c11\u91cf\u7684\u6cbb\u7597\u65b9\u6cd5\u53ef\u4ee5\u6cbb\u7597\u67d0\u4e9b\u75c7\u72b6\uff0c\u4f46\u76ee\u524d\u8fd8\u65e0\u6cd5\u6cbb\u6108\u3002\u5e15\u91d1\u68ee\u75c5\u60a3\u8005\u6025\u9700\u65b0\u7684\u6cbb\u7597\u65b9\u6cd5\u6765\u51cf\u7f13\u6216\u963b\u6b62\u75be\u75c5\u7684\u8fdb\u5c55\uff0c\u63d0\u9ad8\u751f\u6d3b\u8d28\u91cf\u3002 \u201d\u805a\u96c6\u7684\u86cb\u767d\u8d28\u9519\u8bef\u6298\u53e0\u03b1-\u7a81\u89e6\u6838\u86cb\u767d\u5e7f\u6cdb\u5206\u5e03\u4e8e\u4e2a\u4eba\u7684\u5927\u8111\u53d7\u8fd9\u4e9b\u75be\u75c5\u5f71\u54cd,\u51cf\u5c11\u7d2f\u79ef,ATH434\u6f5c\u5728\u6539\u5584\u8fd9\u4e9b\u6bc1\u706d\u6027\u7684\u6761\u4ef6\u7684\u975e\u673a\u52a8\u8f66\u53d1\u52a8\u673a\u548c\u75c7\u72b6,\u201d\u6c83\u7eb3Poewe\u535a\u58eb\u7814\u7a76\u5458\u8fc8\u514b\u5c14J\u798f\u514b\u65af\u57fa\u91d1\u4f1a\u548c\u5965\u5730\u5229\u56e0\u65af\u5e03\u9c81\u514b\u533b\u79d1\u5927\u5b66\u7684\u795e\u7ecf\u5b66\u6559\u6388,\u8bf4\u3002 \u201c\u6211\u671f\u5f85\u770b\u5230\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5242\u91cf\u4f18\u5316\u7814\u7a76\u7684\u7ed3\u679c\uff0c\u4ee5\u53ca\u8fd9\u4e00\u9002\u5e94\u75c7\u7684\u672a\u6765\u53d1\u5c55\uff0c\u201d\u4ed6\u8865\u5145\u9053\u3002 \u8be5\u9879\u76ee\u5c06\u7531\u8303\u5fb7\u6bd4\u5c14\u7279\u5927\u5b66\u533b\u5b66\u4e2d\u5fc3\u975e\u4e34\u5e8a\u53d1\u5c55\u526f\u4e3b\u4efbMargaret Bradbury\u535a\u58eb\u3001\u795e\u7ecf\u75c5\u5b66\u526f\u6559\u6388Daniel Claassen\u535a\u58eb\u4ee5\u53ca\u5f17\u6d1b\u91cc\u795e\u7ecf\u79d1\u5b66\u548c\u7cbe\u795e\u5065\u5eb7\u7814\u7a76\u6240PD\u7814\u7a76\u5b9e\u9a8c\u5ba4\u4e3b\u4efbDavid Finkelstein\u535a\u58eb\u9886\u5bfc\u3002 \u5bfb\u627e\u6cbb\u7597\u65b9\u6cd5 Michael J Fox\u57fa\u91d1\u4f1a\u4e8e2000\u5e74\u7531\u597d\u83b1\u575e\u8457\u540d\u6f14\u5458\u3001Back to the Future\u4e2d\u7684\u660e\u661fMichael J Fox\u521b\u7acb\u30021991\u5e74\uff0c29\u5c81\u7684\u8fc8\u514b\u5c14\u88ab\u8bca\u65ad\u51fa\u60a3\u6709\u5e15\u91d1\u68ee\u75c7\u3002 \u8be5\u57fa\u91d1\u4f1a\u81f4\u529b\u4e8e\u901a\u8fc7\u79ef\u6781\u8d44\u52a9\u7684\u7814\u7a76\u8bae\u7a0b\u627e\u5230\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u7684\u65b9\u6cd5\uff0c\u5e76\u786e\u4fdd\u6539\u5584\u6cbb\u7597\u65b9\u6cd5\u7684\u53d1\u5c55\uff0c\u4e3a\u4eca\u5929\u7684\u5e15\u91d1\u68ee\u60a3\u8005\u63d0\u4f9b\u5e2e\u52a9\u3002 \u8be5\u57fa\u91d1\u4f1a\u58f0\u79f0\u8fc4\u4eca\u4e3a\u6b62\u5df2\u7ecf\u8d44\u52a9\u4e86\u8d85\u8fc710\u4ebf\u7f8e\u5143(13\u4ebf\u6fb3\u5143)\u7684\u7814\u7a76\u9879\u76ee\u3002<\/p>\n","protected":false},"author":5,"featured_media":10768,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[403],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-09T02:19:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Alterity-Therapeutics-ASX-ATH-Michael-J.-Fox-Foundation-Parkinsons-disease-clinical-trials-ATH434.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9\" \/>\n<meta name=\"twitter:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Alterity-Therapeutics-ASX-ATH-Michael-J.-Fox-Foundation-Parkinsons-disease-clinical-trials-ATH434.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/\",\"name\":\"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-02-09T02:19:21+00:00\",\"dateModified\":\"2023-08-29T18:01:52+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9","description":"\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9","og_description":"\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/","og_site_name":"smallcapsCN","article_published_time":"2021-02-09T02:19:21+00:00","article_modified_time":"2023-08-29T18:01:52+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Alterity-Therapeutics-ASX-ATH-Michael-J.-Fox-Foundation-Parkinsons-disease-clinical-trials-ATH434.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9","twitter_description":"\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Alterity-Therapeutics-ASX-ATH-Michael-J.-Fox-Foundation-Parkinsons-disease-clinical-trials-ATH434.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/","url":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/","name":"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-02-09T02:19:21+00:00","dateModified":"2023-08-29T18:01:52+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u751f\u7269\u6280\u672f\u516c\u53f8Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86Michael J Fox\u57fa\u91d1\u4f1a\u5e15\u91d1\u68ee\u7814\u7a76\u57fa\u91d1\u7684\u8d44\u52a9\uff0c\u4ee5\u786e\u5b9a\u5176\u9886\u5148\u5019\u9009\u836f\u7269ATH434\u5728\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u6700\u4f73\u5242\u91cf\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-funding-michael-j-fox-foundation-parkinsons-disease-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Alterity Therapeutics\u63a5\u53d7Michael J Fox\u57fa\u91d1\u4f1a\u5bf9\u5e15\u91d1\u68ee\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u52a9"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2637"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2637"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2637\/revisions"}],"predecessor-version":[{"id":10767,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2637\/revisions\/10767"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10768"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}